BRITTANY HANSON: Open Payments
NPI 1942767405 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,544 in 116 payments from 14 companies in 2025. Trend: 2023 $2,909 · 2024 $3,252 · 2025 $2,544
Food & beverage: $2,544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $1,055 |
| Madrigal Pharmaceuticals | 10 | $459 |
| Janssen Biotech, Inc. | 10 | $276 |
| Regeneron Healthcare Solutions, Inc. | 6 | $142 |
| QOL Medical, LLC | 4 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $103 |
| Ardelyx, Inc. | 5 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
| Phathom Pharmaceuticals, Inc. | 8 | $54 |
| GENZYME CORPORATION | 2 | $52 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, SKYRIZI, DUPIXENT, Sucraid, LINZESS, ENTYVIO.
Industry payments across NY — which companies pay providers there.
